Last reviewed · How we verify

NCT03226002

Which Nostril Should be Used for Nasotracheal Intubation With Airtraq NT®: the Right or Left? A Randomized Clinical Trial

Completed NA Last updated 7 August 2018
What this trial tests

NA trial testing Airtraq NT in Nasotracheal Intubation in 35 participants. Completed in 10 September 2017.

Timeline
1 April 2017
Primary endpoint
1 September 2017
10 September 2017

Quick facts

Lead sponsorKocaeli University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment35
Start date1 April 2017
Primary completion1 September 2017
Estimated completion10 September 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli University

Who can join

Adults 18 to 65, any sex, with Nasotracheal Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After Ethics committee approval investigators decided to enroll 40 patients ASA I-II, 18-60 years of age undergoing maxillofascial, oral and double chin surgery to determine which nostril is more suitable for nasotracheal intubation with nasotracheal Airtraq. We primay aimed to compare the glottis visualization time, intubation time and total intubation times.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Which nostril should be used for nasotracheal intubation with Airtraq NT®: the right or left? A randomized clinical trial
    Arslan Zİ, Türkyılmaz N. · · 2019 · cited 9× · PMID 30762320 · DOI 10.3906/sag-1803-177

Verify or expand the search:

Other recruiting trials for Nasotracheal Intubation

Currently open trials in the same condition.

Other Kocaeli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03226002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing